PURPOSE: Work loss is one of many personal costs for patients with cancer and their families. Many women with breast cancer face long-term job loss that stems from their diagnoses. However, little is known about the economic and employment outcomes of partners of women with breast cancer. METHODS: Women with nonmetastatic breast cancer identified by the Detroit and Los Angeles SEER registries between June 2005 and February 2007 were surveyed at both 9 months and 4 years after diagnosis. Partners were surveyed 4 years after patients' diagnoses. Nonretired partners were asked about employment and financial consequences that stemmed from the patients' breast cancer diagnoses and treatments. RESULTS: A total of 517 (67%) of 774 eligible partners completed the survey; 32% reported worsened financial status attributed to patients' breast cancers. Two hundred forty nonretired partners worked during the year after the patients' diagnoses; 90% were still working 4 years postdiagnosis. A total of 32% of partners decreased their work hours as a result of patients' breast cancer diagnoses and treatments; 64% of partners reported that, as a result of patients' breast cancer diagnoses and treatments, it was very/extremely important to keep working to keep health insurance. Overall, 51% of partners reported that it was very/extremely important to avoid changing jobs, because they were worried about loss of health insurance. CONCLUSION: Nearly one third of partners reported that their financial status was worse because of the patient's breast cancer, although most remained working 4 years after a diagnosis. Partners may continue to work longer than desired to compensate for a loss of financial resources in the family.
PURPOSE: Work loss is one of many personal costs for patients with cancer and their families. Many women with breast cancer face long-term job loss that stems from their diagnoses. However, little is known about the economic and employment outcomes of partners of women with breast cancer. METHODS:Women with nonmetastatic breast cancer identified by the Detroit and Los Angeles SEER registries between June 2005 and February 2007 were surveyed at both 9 months and 4 years after diagnosis. Partners were surveyed 4 years after patients' diagnoses. Nonretired partners were asked about employment and financial consequences that stemmed from the patients' breast cancer diagnoses and treatments. RESULTS: A total of 517 (67%) of 774 eligible partners completed the survey; 32% reported worsened financial status attributed to patients' breast cancers. Two hundred forty nonretired partners worked during the year after the patients' diagnoses; 90% were still working 4 years postdiagnosis. A total of 32% of partners decreased their work hours as a result of patients' breast cancer diagnoses and treatments; 64% of partners reported that, as a result of patients' breast cancer diagnoses and treatments, it was very/extremely important to keep working to keep health insurance. Overall, 51% of partners reported that it was very/extremely important to avoid changing jobs, because they were worried about loss of health insurance. CONCLUSION: Nearly one third of partners reported that their financial status was worse because of the patient's breast cancer, although most remained working 4 years after a diagnosis. Partners may continue to work longer than desired to compensate for a loss of financial resources in the family.
Authors: Victoria Blinder; Sujata Patil; Carolyn Eberle; Jennifer Griggs; Rose C Maly Journal: Breast Cancer Res Treat Date: 2013-07-25 Impact factor: 4.872
Authors: B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan Journal: J Clin Epidemiol Date: 1998-11 Impact factor: 6.437
Authors: Eva Grunfeld; Doug Coyle; Timothy Whelan; Jennifer Clinch; Leonard Reyno; Craig C Earle; Andrew Willan; Raymond Viola; Marjorie Coristine; Teresa Janz; Robert Glossop Journal: CMAJ Date: 2004-06-08 Impact factor: 8.262
Authors: Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John J Graff; Nancy K Janz; Monica Morrow; Reshma Jagsi; Barbara Salem; Steven J Katz Journal: J Natl Cancer Inst Date: 2009-08-31 Impact factor: 13.506
Authors: Mahasin S Mujahid; Nancy K Janz; Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2010-10-09 Impact factor: 4.442
Authors: Bahaa Kazzi; Fumiko Chino; Brigitte Kazzi; Bhav Jain; Sibo Tian; Joseph A Paguio; J Seth Yao; Vinayak Muralidhar; Brandon A Mahal; Paul L Nguyen; Nina N Sanford; Edward Christopher Dee Journal: Support Care Cancer Date: 2022-07-25 Impact factor: 3.359
Authors: Shoshana Adler Jaffe; Dolores D Guest; Andrew L Sussman; Charles L Wiggins; Jessica Anderson; Jean A McDougall Journal: Cancer Causes Control Date: 2021-06-27 Impact factor: 2.506
Authors: Christine M Veenstra; Katrina R Ellis; Paul Abrahamse; Kevin C Ward; Arden M Morris; Sarah T Hawley Journal: BMC Cancer Date: 2022-10-13 Impact factor: 4.638
Authors: Debbie W Chen; David Reyes-Gastelum; Christine M Veenstra; Ann S Hamilton; Mousumi Banerjee; Megan R Haymart Journal: Thyroid Date: 2020-09-22 Impact factor: 6.568
Authors: Erin E Cook; Shoshana M Rosenberg; Kathryn J Ruddy; William T Barry; Mary Greaney; Jennifer Ligibel; Kim Sprunck-Harrild; Michelle D Holmes; Rulla M Tamimi; Karen M Emmons; Ann H Partridge Journal: BMC Public Health Date: 2020-10-06 Impact factor: 3.295
Authors: Christine M Veenstra; Thomas M Braun; Paul H Abrahamse; Daniela Wittmann; Sarah T Hawley Journal: Cancer Med Date: 2022-02-03 Impact factor: 4.711